Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	19782
Country	Türkiye

Received	2015-05-21 08:50
Peer-Review Started	2015-05-22 09:45
To Make the First Decision	2015-06-25 17:53
Return for Revision	2015-07-01 08:32
Revised	2015-07-22 19:03
Second Decision	2015-10-14 08:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-10-27 18:27
Articles in Press	2015-10-27 18:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-03 19:13
Publish the Manuscript Online	2015-12-14 21:02

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Targeted therapy for advanced gastric cancer: A review of current status and future prospects
Manuscript Source	Invited Manuscript
All Author List	Ozkan Kanat, Bert O’Neil and Safi Shahda
Funding Agency and Grant Number
Corresponding Author	Ozkan Kanat, MD, PhD, Professor, Department of Medical Oncology, Uludag University faculty of Medicine, McIntyre Medical Building, 3655 Sir William Osler Montreal, Quebec H3G1Y6, 16059 Bursa, Turkey. ozkanat@uludag.edu.tr
Key Words	Gastric cancer; Targeted therapy; Angio­genesis; Epidermal growth factor; Treatment
Core Tip	Systemic chemotherapy confers a modest survival advantage in patients with advanced gastric cancer. The new therapeutic agents that target various inter- and intracellular signaling transduction pathways offer the promise of improved clinical outcomes in selected patients. The success of some of these agents has changed the treatment paradigm for advanced gastric cancer. We herein discuss the current and potential future roles of targeted therapy in the manage-ment of this malignancy.
Publish Date	2015-12-14 21:02
Citation	Kanat O, O’Neil B, Shahda S. Targeted therapy for advanced gastric cancer: A review of current status and future prospects. World J Gastrointest Oncol 2015; 7(12): 401-410
URL	http://www.wjgnet.com/1948-5204/full/v7/i12/401.htm
DOI	http://dx.doi.org/10.4251/wjgo.v7.i12.401

Full Article (PDF)	WJGO-7-401.pdf
Full Article (Word)	WJGO-7-401.doc
Manuscript File	19782-Review.docx
Answering Reviewers	19782-Answering reviewers.pdf
Audio Core Tip	19782-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19782-Conflict-of-interest statement.pdf
Copyright License Agreement	19782-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	19782-Language certificate.pdf
Peer-review Report	19782-Peer-review(s).pdf
Scientific Misconduct Check	19782-Scientific misconduct check.pdf
Scientific Editor Work List	19782-Scientific editor work list.pdf